UV Light-mediated Corneal Crosslinking as (Lymph)Angioregressive Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [CrossCornealVision]
The trial evaluates the effect of corneal crosslinking as pre-treatment before corneal transplantation. The goal is to improve graft survival by reducing pathological vessels through pre-treatment.
⁃ Medical condition or disease to be investigated:
⁃ \- Pathologically prevascularized cornea with need for corneal transplantation
⁃ Further inclusion criteria:
• Written informed consent by subject and/or witness prior to any study-related procedures
• Adult male and female subjects ≥ 18 years old
• ≥ 2 corneal quadrants covered by pathological corneal neovascularization
• Absence of other clinical contraindications to any part or product of the treatment plan
• A cooperative attitude to follow up the study procedures
• In case of bilateral disease only one eye will be included
• Steroid responders with adequate control regiment or local/systemic therapy can be included